Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Vladimir, Vimberg"'
Autor:
Ilona Bereczki, Vladimir Vimberg, Eszter Lőrincz, Henrietta Papp, Lajos Nagy, Sándor Kéki, Gyula Batta, Ana Mitrović, Janko Kos, Áron Zsigmond, István Hajdú, Zsolt Lőrincz, Dávid Bajusz, László Petri, Jan Hodek, Ferenc Jakab, György M. Keserű, Jan Weber, Lieve Naesens, Pál Herczegh, Anikó Borbás
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Patients infected with SARS-CoV-2 risk co-infection with Gram-positive bacteria, which severely affects their prognosis. Antimicrobial drugs with dual antiviral and antibacterial activity would be very useful in this setting. Although glycop
Externí odkaz:
https://doaj.org/article/91f0f017bd784a0087174f5750d3561a
Autor:
Marketa Koberska, Ludmila Vesela, Vladimir Vimberg, Jakub Lenart, Jana Vesela, Zdenek Kamenik, Jiri Janata, Gabriela Balikova Novotna
Publikováno v:
mBio, Vol 12, Iss 5 (2021)
Resistance proteins are perceived as mechanisms protecting bacteria from the inhibitory effect of their produced antibiotics or antibiotics from competitors. Here, we report that antibiotic resistance proteins regulate lincomycin biosynthesis in resp
Externí odkaz:
https://doaj.org/article/3bd1fc7128384750a9b8a74a263ebdfe
Autor:
Vladimir Vimberg, Leona Zieglerová, Karolína Buriánková, Pavel Branny, Gabriela Balíková Novotná
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
vanZ, a member of the VanA glycopeptide resistance gene cluster, confers resistance to lipoglycopeptide antibiotics independent of cell wall precursor modification by the vanHAX genes. Orthologs of vanZ are present in the genomes of many clinically r
Externí odkaz:
https://doaj.org/article/383d821feee84468b4d42968c506330b
Autor:
Vladimir Vimberg, Leona Zieglerova, Aninda Mazumdar, Zsolt Szűcs, Aniko Borbás, Pál Herczegh, Gabriela Balikova Novotna
Publikováno v:
Pharmaceuticals, Vol 14, Iss 11, p 1182 (2021)
The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics inclu
Externí odkaz:
https://doaj.org/article/17c1c0e3cb234f2b884059fda98a0fcd
Autor:
Vladimir Vimberg
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1227 (2021)
Teicoplanin is an antibiotic that has been actively used in medical practice since 1986 to treat serious Gram-positive bacterial infections. Due to its efficiency and low cytotoxicity, teicoplanin has also been used for patients with complications, i
Externí odkaz:
https://doaj.org/article/400111bfe39345e495f2dbf846cbf585
Autor:
Vishma Pratap Sur, Aninda Mazumdar, Vladimir Vimberg, Tommaso Stefani, Ladislav Androvic, Lucie Kracikova, Richard Laga, Zdenek Kamenik, Katerina Komrskova
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 97, p 97 (2022)
International Journal of Molecular Sciences; Volume 23; Issue 1; Pages: 97
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 23; Issue 1; Pages: 97
International Journal of Molecular Sciences
Teicoplanin is a natural lipoglycopeptide antibiotic with a similar activity spectrum as vancomycin; however, it has with the added benefit to the patient of low cytotoxicity. Both teicoplanin and vancomycin antibiotics are actively used in medical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc49550355f91feee017d70d8f2b602f
https://www.mdpi.com/1422-0067/23/1/97
https://www.mdpi.com/1422-0067/23/1/97
Autor:
Vishma Pratap Sur, Ondrej Simonik, Michaela Novotna, Aninda Mazumdar, Frantisek Liska, Vladimir Vimberg, Katerina Komrskova
Publikováno v:
International journal of biological macromolecules. 219
Toxin-antitoxin (TA) systems are small genetic elements which encode toxin proteins that interfere with vital cellular functions. PepA1 and PepG1 toxin proteins, known also as SprA1 and SprG1, are type I TA. In Staphylococcus aureus (S. aureus), thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367487196bf6c53050ac89c0698a009c
https://pubmed.ncbi.nlm.nih.gov/35932805
https://pubmed.ncbi.nlm.nih.gov/35932805
Autor:
Anikó Borbás, Leona Zieglerova, Zsolt Szűcs, Aninda Mazumdar, Pál Herczegh, Vladimir Vimberg, Gabriela Balikova Novotna
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1182, p 1182 (2021)
Pharmaceuticals
Volume 14
Issue 11
Pharmaceuticals
Volume 14
Issue 11
The increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993ccbed82e6a9efb580c6e89d86794c
https://www.mdpi.com/1424-8247/14/11/1182
https://www.mdpi.com/1424-8247/14/11/1182
Autor:
Karolína Buriánková, Pavel Branny, Aninda Mazumdar, Vladimir Vimberg, Gabriela Balikova Novotna
Publikováno v:
Medicinal research reviewsREFERENCES. 42(3)
Several natural antimicrobial peptides (AMPs), including the novel semisynthetic lipoglycopeptide antibiotics telavancin, dalbavancin, and oritavancin, have been approved for clinical use to address the growing problem of multiple antibiotic-resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54acbe4b2b80ca7e7e8a51199fced7ec
https://pubmed.ncbi.nlm.nih.gov/34796517
https://pubmed.ncbi.nlm.nih.gov/34796517
Autor:
Marketa Koberska, Maria Pain, Jana Vesela, Bich Nguyen Thi Ngoc, Vladimir Vimberg, Gabriela Balikova Novotna, Michaela Novotná, Jorunn Pauline Cavanagh, Jakub Lenart
Publikováno v:
Antimicrob Agents Chemother
Vga(A) protein variants confer different levels of resistance to lincosamides, streptogramin A, and pleuromutilins (LS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b3af32b8ed165586b061bce6dca09f
https://doi.org/10.1128/aac.02242-20
https://doi.org/10.1128/aac.02242-20